Boston Scientific Corpora... (BSX)
NYSE: BSX
· Real-Time Price · USD
102.91
-1.24 (-1.19%)
At close: Aug 15, 2025, 12:46 PM
Boston Scientific Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 672M | 562M | 700M | 324M | 493M | 504M | 504M | 270M | 314M | 140M | 188M | 260M | 110M | 95M | 419M | 186M | 341M |
Depreciation & Amortization | 325M | 348M | 636M | 311M | 304M | 313M | 300M | 298M | 285M | 294M | 284M | 284M | 274M | 290M | 272M | 263M | 268M |
Stock-Based Compensation | 74M | 69M | -61M | 195M | 63M | 59M | 59M | 60M | 55M | 55M | 58M | 55M | 52M | 49M | 51M | 47M | 47M |
Other Working Capital | -77M | -159M | 17M | -71M | -55M | 53M | 12M | -14M | -41M | 89M | -54M | -104M | -140M | 11M | 55M | -72M | -128M |
Other Non-Cash Items | 107M | 233M | -428M | 202M | 16M | 65M | 40M | 108M | 40M | -23M | 222M | 78M | 263M | 154M | -105M | -14M | -18M |
Deferred Income Tax | 41M | -80M | -11M | -10M | 31M | 73M | -29M | -64M | 19M | 7M | 23M | -18M | -75M | -75M | 39M | -87M | -1M |
Change in Working Capital | -678M | 324M | 166M | -209M | -743M | -57M | -176M | -14M | -523M | 334M | -304M | -353M | -682M | -35M | -211M | 248M | -353M |
Operating Cash Flow | 541M | 1.46B | 1B | 813M | 164M | 957M | 698M | 658M | 190M | 807M | 471M | 306M | -58M | 478M | 465M | 643M | 284M |
Capital Expenditures | -187M | -293M | -304M | -155M | -245M | -267M | -206M | -206M | -121M | -200M | -172M | -105M | -131M | -266M | -107M | -106M | -75M |
Cash Acquisitions | -239M | -3.42B | -1.13B | -48M | -47M | -793M | 1M | -643M | -375M | -5M | -71M | 1M | -1.47B | -244M | -1.31B | 3M | 95M |
Purchase of Investments | n/a | n/a | n/a | -73M | -66M | -28M | -16M | -63M | n/a | 15M | -22M | 1M | -15M | 51M | -21M | -17M | -13M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 28M | 15M | 2M | n/a | 70M | 22M | -2M | 32M | n/a | 207M | 84M | 25M |
Other Investing Acitivies | -74M | -9M | -121M | 5M | 7M | 7M | 9M | 70M | 2M | -63M | 18M | 76M | 11M | -2M | 22M | 36M | 39M |
Investing Cash Flow | -500M | -3.7B | -1.43B | -271M | -285M | -1.05B | -197M | -840M | -484M | -183M | -225M | -29M | -1.57B | -461M | -1.21B | n/a | 71M |
Debt Repayment | 247M | 189M | 22M | n/a | 1.62B | n/a | -41M | 37M | n/a | n/a | -155M | -11M | 1M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | 80M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 52M | n/a | n/a | n/a | 18M |
Dividend Paid | n/a | n/a | -23M | n/a | n/a | n/a | n/a | -14M | -14M | -13M | -14M | -14M | -14M | -13M | -14M | -14M | -14M |
Other Financial Acitivies | -14M | -3M | -88M | -2M | -127M | -2M | -18M | -7M | -55M | -5M | -89M | -325M | -45M | -3M | -44M | -4M | -99M |
Financial Cash Flow | 233M | 214M | 7M | 24M | 1.57B | 15M | 16M | 43M | -69M | 1M | -199M | -344M | -6M | -8M | 6M | 2M | -95M |
Net Cash Flow | 313M | -2.04B | -413M | 566M | 1.44B | -77M | 512M | -144M | -363M | 629M | 42M | -63M | -1.64B | 11M | -739M | 642M | 258M |
Free Cash Flow | 354M | 1.16B | 698M | 658M | -81M | 690M | 492M | 452M | 69M | 607M | 298M | 202M | -189M | 212M | 358M | 537M | 209M |